MTX-652

N/A

Report date: 2023/12/19 11:04:04
NME

Base Information

Drug NameMTX-652
Drug Alias NameMTX-652
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUbiquitin carboxyl-terminal hydrolase 30 inhibitors
TargetsUbiquitin carboxyl-terminal hydrolase 30
Therapy Area/IndicationsAcute Kidney Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMission Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesMission Therapeutics
Inactive CompaniesN/A
Active IndicationsAcute Kidney Injury
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A